Clinical manifestations and outcomes of pediatric chronic neutropenia

Clinical manifestations and outcomes of pediatric chronic neutropenia

Neutropenia is a decrease in the number of circulating neutrophils. When neutropenia persists for more than 3 months, it becomes chronic. A heterogeneous group of diseases in children can cause chronic neutropenia. The aim of the present study was to categorize the diseases and present their clinica...

Full description

Bibliographic Details
Main Authors:	Chuan Wan, Hsin-Hui Yu, Meng-Yao Lu, Jyh-Hong Lee, Li-Chieh Wang, Yu-Tsan Lin, Yao-Hsu Yang, Bor-Luen Chiang
Format:	Article
Language:	English
Published:	Elsevier 2012-04-01
Series:	Journal of the Formosan Medical Association
Subjects:	granulocyte colony-stimulating factor immunodeficiency neutropenia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664612000319

Similar Items

Neutropenia in pediatric hematology/oncology practice
by: E. A. Deordieva, et al.
Published: (2015-06-01)

Neutropenia in pediatric hematology/oncology practice
by: E. A. Deordieva, et al.
Published: (2015-06-01)

Simultaneous treatment with carbimazole and granulocyte-colony stimulating factor in a patient with thyrotoxicosis and carbimazole induced neutropenia
by: Talapatra Indrajit, et al.
Published: (2006-12-01)

Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
by: I. B. Kononenko, et al.
Published: (2020-11-01)

Role of biosimilars in neutropenia prevention in cancer patients
by: V. V. Ptushkin
Published: (2015-01-01)

Role of biosimilars in neutropenia prevention in cancer patients
by: V. V. Ptushkin
Published: (2015-01-01)

Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
by: Guariglia R, et al.
Published: (2016-01-01)

Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01)

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
by: Yi Ba, et al.
Published: (2020-11-01)

Caracterización de pacientes pediátricos con neutropenia enviados a un hospital de referencia Characterization of neutropenic pediatric patients sent to a referral centre
by: Gustavo Adolfo Lazo-Páez, et al.
Published: (2010-06-01)

Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations
by: V. V. Ptushkin, et al.
Published: (2015-06-01)

Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations
by: V. V. Ptushkin, et al.
Published: (2015-06-01)

Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim
by: Ka‐Won Kang, et al.
Published: (2020-09-01)

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
by: Yosuke Dotsu, et al.
Published: (2021-09-01)

Chronic Refractory Uveitis in a Patient with Childhood-Onset Cyclic Neutropenia
by: Li-Li Chen, et al.
Published: (2011-05-01)

Recombinant Ganoderma lucidum Immunomodulatory Protein Improves the Treatment for Chemotherapy-Induced Neutropenia
by: Xinhua Lei, et al.
Published: (2020-06-01)

Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia
by: Ru-Jeng Teng, et al.
Published: (2015-02-01)

Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy
by: L Yu Vladimirova, et al.
Published: (2016-09-01)

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
by: Schwartzberg LS, et al.
Published: (2018-09-01)

Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India
by: Vineet Talwar, et al.
Published: (2017-01-01)

Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study
by: Yusuke Kitagawa, et al.
Published: (2020-04-01)

Relato de um caso de neutropenia congênita grave em um lactente jovem A case report of severe congenital neutropenia in a young infant
by: Lucas Fadel M. dos Santos, et al.
Published: (2011-12-01)

A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer
by: Dongling Zou, et al.
Published: (2021-06-01)

Neutrophil Evolution and Their Diseases in Humans
by: Jennifer W. Leiding, et al.
Published: (2017-08-01)

Late onset clozapine induced agranulocytosis
by: Rajmohan Velayudhan, et al.
Published: (2014-01-01)

Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study
by: Derek Weycker, et al.
Published: (2019-08-01)

Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic
by: Wei C, et al.
Published: (2021-04-01)

Neutropenias congénitas Congenital neutropenias
by: Aramís Núñez Quintana, et al.
Published: (2004-04-01)

The safety and clinical efficacy of recombinant human granulocyte colony stimulating factor injection for colon cancer patients undergoing chemotherapy
by: Jie Chen, et al.

White blood cell count and ratıo changes ın newborns after granulocyte colony-stımulatıng factor treatments
by: Melek Buyukeran, et al.
Published: (2021-09-01)

The importance of the prevention of treatment induced neutropenia in patients with malignant neoplasms of the head and neck
by: Editorial Board
Published: (2021-08-01)

Clozapine-Induced Febrile Neutropenia and Cellulitis
by: Selcuk YAYLACI, et al.
Published: (2014-03-01)

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
by: Alshari O, et al.
Published: (2021-09-01)

Modern concepts of biosimilars in hematology and oncology
by: V. V. Ptushkin
Published: (2014-07-01)

Modern concepts of biosimilars in hematology and oncology
by: V. V. Ptushkin
Published: (2014-07-01)

A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors
by: Tetsuya Sasaki, et al.
Published: (2018-01-01)

Comparison of Long-Acting G-CSF (PD-Lasta) with Short-Acting G-CSF (PD-Grastim) in Neutrophil Recovery Following Consolidation Chemotherapy with High-Dose Cytarabine in Acute Myeloid Leukemia: A Randomized Clinical Trial
by: Mohsen Esfandbod, et al.
Published: (2021-04-01)

Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center
by: Emmanuel Andrès, et al.
Published: (2020-03-01)

Prevention and Control of Infections in Patients with Severe Congenital Neutropenia; A Follow up Study
by: Tahmineh Salehi, et al.
Published: (2012-03-01)

The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT
by: Shahrzad Bakhtiar, et al.
Published: (2019-10-01)